The OncAlert® Oral Cancer product line is transforming detection and improving potential outcomes through simple, accurate, and cost-effective solutions to aid in the early detection and intervention of oral cancer (including oral and oropharyngeal cancer).
The OncAlert Oral Cancer LAB Test (“OncAlert LAB Test”) and the the OncAlert Oral Cancer RAPID Test (“OncAlert RAPID Test”) are the first and only commercially available technologies that accurately measure CD44, a tumor-initiating and stem cell-associated biomarker, and total protein levels. These markers are clinically validated to be associated specifically with oral cancer. These tests are optimized for easy use by collecting samples via an oral saline rinse. The test results, along with other clinical factors, aid in the diagnosis of oral cancer. Both products use a simple, oral rinse collection and measurement procedure that is easy to administer and non-invasive for the patient.
Both products are CE Marked and available in select markets outside the United States.Learn More